Somatolink Foundation, Inc.

Somatolink Foundation, Inc. is a US (Delaware) incorporated Public Benefit Corporation research organization developing targeted therapies in oncology and psoriasis based on solid research, biomarker discovery and personalized genomics while using a novel operational model centered on the patient as key stakeholder. Our business model integrates a personalized genomics/diagnostic platform with an expert patient to patient network design to ‘put the patient first’.